Moderna, Inc. (MRNA)
53.94
+0.63
(+1.18%)
USD |
NASDAQ |
Mar 17, 16:00
54.19
+0.25
(+0.46%)
After-Hours: 18:55
Moderna Market Cap : 21.30B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 179.27B |
| Johnson & Johnson | 573.92B |
| Eli Lilly & Co. | 831.00B |
| Merck & Co., Inc. | 286.50B |
| Arbutus Biopharma Corp. | 839.49M |
Market Cap Related Metrics
| PS Ratio | 10.79 |
| Price to Book Value | 2.463 |
| Price | 53.94 |
| Earnings Yield | -13.46% |